Indraprastha Medical Corporation Ltd

Pursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Tuesday the 3rd February 2026 i.e. today considered and approved the following :-1. Considered and approved unaudited financial results of the Company for the quarter and nine months ended on 31st December 2025.2. Noted additional affidavit filed by Govt. of NCT of Delhi in the pending Free Patient Matter i.e. SLP (C) No. 29482/2009.3. Appointed Mr. Harsh Pati Singhania as an additional Director in the category of Non-executive Independent Director for a period of five years.4. Reappointed Mr. Salil Singhal as an Independent Director for second consecutive term of five years.5. Reappointed Ms. Vineeta Rai as an Independent Director for second consecutive term of five years.6. Reappointed Ms. Madhumita Ganguli as Independent Director for second consecutive term of five years.